These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 10197084)

  • 1. Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment.
    Boot AM; Nauta J; de Jong MC; Groothoff JW; Lilien MR; van Wijk JA; Kist-van Holthe JE; Hokken-Koelega AC; Pols HA; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):665-72. PubMed ID: 10197084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone density and body composition in chronic renal failure: effects of growth hormone treatment.
    van der Sluis IM; Boot AM; Nauta J; Hop WC; de Jong MC; Lilien MR; Groothoff JW; van Wijk AE; Pols HA; Hokken-Koelega AC; de Muinck Keizer-Schrama SM
    Pediatr Nephrol; 2000 Dec; 15(3-4):221-8. PubMed ID: 11149115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency.
    Boot AM; Engels MA; Boerma GJ; Krenning EP; De Muinck Keizer-Schrama SM
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2423-8. PubMed ID: 9253311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study.
    Lanes R; Gunczler P; Esaa S; Weisinger JR
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):725-30. PubMed ID: 12460321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
    Lem AJ; van der Kaay DC; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty.
    Boot AM; De Muinck Keizer-Schrama S; Pols HA; Krenning EP; Drop SL
    J Clin Endocrinol Metab; 1998 Feb; 83(2):370-3. PubMed ID: 9467543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation of bone acquisition during growth hormone treatment in children can be explained by proteomic biomarkers, bone formation markers, body composition and nutritional factors.
    Swolin-Eide D; Andersson B; Hellgren G; Magnusson P; Albertsson-Wikland K
    Bone; 2018 Nov; 116():144-153. PubMed ID: 30071306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density and effects of growth hormone treatment in prepubertal children with Prader-Willi syndrome: a randomized controlled trial.
    de Lind van Wijngaarden RF; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; van Leeuwen M; Haring DA; Bocca G; Mieke Houdijk EC; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3763-71. PubMed ID: 19622627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.
    Bakker NE; Kuppens RJ; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Bindels-de Heus GC; Bocca G; Haring DA; Hoorweg-Nijman JJ; Houdijk EC; Jira PE; Lunshof L; Odink RJ; Oostdijk W; Rotteveel J; Van Alfen AA; Van Leeuwen M; Van Wieringen H; Wegdam-den Boer ME; Zwaveling-Soonawala N; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1609-18. PubMed ID: 25668198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
    Lanes R
    Curr Pharm Biotechnol; 2000 Jul; 1(1):33-46. PubMed ID: 11467359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial.
    Sass TC; De Muinck Keizer-Schrama SM; Stijnen T; Asarfi A; Van Leeuwen WJ; Van Teunenbroek A; Van Rijn RR; Drop SL
    Clin Endocrinol (Oxf); 2000 May; 52(5):531-6. PubMed ID: 10792330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recombinant growth hormone (GH) treatment on bone mineral density and body composition in adults with childhood onset growth hormone deficiency.
    Sartorio A; Ortolani S; Conti A; Cherubini R; Galbiati E; Faglia G
    J Endocrinol Invest; 1996 Sep; 19(8):524-9. PubMed ID: 8905475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-term treatment with GH in the bone mineral density of adults with hypopituitarism and GH deficiency and after discontinuation of GH replacement.
    Gómez JM; Gómez N; Fiter J; Soler J
    Horm Metab Res; 2000 Feb; 32(2):66-70. PubMed ID: 10741688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
    Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in body composition of children with chronic renal failure on growth hormone.
    Johnson VL; Wang J; Kaskel FJ; Pierson RN
    Pediatr Nephrol; 2000 Jul; 14(7):695-700. PubMed ID: 10912545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density in children with acute lymphoblastic leukaemia.
    Boot AM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
    Eur J Cancer; 1999 Nov; 35(12):1693-7. PubMed ID: 10674015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: a 6-year follow-up study.
    van der Sluis IM; Boot AM; Hop WC; De Rijke YB; Krenning EP; de Muinck Keizer-Schrama SM
    Horm Res; 2002; 58(5):207-14. PubMed ID: 12401939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone treatment in children with rheumatic disease, corticosteroid induced growth retardation, and osteopenia.
    Grote FK; Van Suijlekom-Smit LW; Mul D; Hop WC; Ten Cate R; Oostdijk W; Van Luijk W; Jansen-van Wijngaarden CJ; De Muinck Keizer-Schrama SM
    Arch Dis Child; 2006 Jan; 91(1):56-60. PubMed ID: 16223747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.